Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2024; 70(2): 3-11

Activation of ATP-sensitive potassium channels prevents doxorubicin-induced mitochondrial dysfunction in the heart and impaired vascular responses in rats

M.V. Denysova, N.A. Strutynska, L.A. Mys, Y.P. Korkach, V.F. Sagach, R.B. Strutynskyi

    Bogomoletz Institute of Physiology National Academy of Sciences of Ukraine, Kyiv, Ukraine


One of the side effects of the anticancer drug doxorubicin is its mitotoxicity. At the same time, a sufficient number of functioning mitochondria is required for normal energy supply to the heart. The system of ATP-sensitive potassium channels (KATP -channels) of cytoplasmic and mitochondrial membranes is considered to be the central metabolic sensor of energy supply, and their opening triggers mechanisms of protection against cell damage and death under the influence of pathological factors. The aim of our study was to investigate the effect of KATP-channel opener flocalin on doxorubicin-induced mitochondrial dysfunction in the heart, impaired vascular contraction-relaxation function, and oxidative stress. Acute cardiotoxicity was modelled by short-term intraperitoneal injection of doxorubicin in a total dose of 15 mg/kg. To prevent damage, animals were administered flocalin at a dose of 2.5 mg/kg for 5 consecutive days. It was found that the rate of formation of superoxide anion (•O2 - ) and hydroxyl radical (•OH) in the heart mitochondria significantly increased after administration of doxorubicin by 10.5 and 3.4 times, respectively, and the level of H2O2 increased by 5.3 times. When rats were administered flocalin against the background of doxorubicin, oxidative stress indicators were significantly reduced, namely, the rate of •O2 - and •ON generation was 4 and 1.6 times lower, respectively, and the H2O2 levels were 4.6 times lower. Under conditions of impaired redox status in the rat heart after doxorubicin administration, mitochondrial permeability transition pore opening was activated: the amplitude of spontaneous swelling doubled, and Ca2+-induced swelling increased 1.5-fold. The use of flocalin reduced the amplitude of mitochondrial swelling in calcium-free medium by 84.6%, and under the conditions of action inducer of mPTP opening calcium, this index was restored to control values. Endothelium-dependent relaxation of aorta preparations of doxorubicin-treated animals to acetylcholine (0.1 μmol/l) was 47% less than in the control group. Contractions of aortic rings in these animals under the influence of norepinephrine (10 μmol/l) were reduced by 59% compared to control rats. When flocalin, a KATP-channel opener, was injected into rats, the contractile responses of isolated rat aortic rings were restored almost to the values of control animals, while the endothelium-dependent vasodilator effects of acetylcholine (0.1 μmol/l) under the influence of flocalin were restored by 69% compared with animals injected with doxorubicin. Thus, the opening of KATP-channels by flocalin prevents doxorubicininduced mitochondrial dysfunction in the heart, reduces oxidative stress and prevents vascular contractionrelaxation disorders.

Keywords: doxorubicin; KATP-channels; flocalin; mPTP; oxidative stress; heart; vascular responses.


  1. Wallace R. Mitochondrial mechanisms of doxorubicin cardiotoxicity. Cir Res. 2020; 126:926-41. CrossRef PubMed PubMedCentral
  2. Pang B, Qiao X, Janssen L, Velds A, Groothuis T, Kerkhoven R, Nieuwland, Drug-induced histone evolution from open chromatin contributes to the chemotherapeutic effects of doxorubicin. Nat Commun. 2013; 4:1908. CrossRef PubMed PubMedCentral
  3. Nitiss JL. Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer. 2009; 9:338-50. CrossRef PubMed PubMedCentral
  4. Murabito A, Hirsch E, Ghigo A. Mechanisms of anthracycline-induced cardiotoxicity: Is mitochondrial dysfunction the answer? Front Cardiovascul Med. 2020; 7:35. CrossRef PubMed PubMedCentral
  5. Denysova MV, Strutynska NA, Mys LA, Korkach YuV, Rozova RV, Sagach VF. Development of mitochondrial dysfunction in the acute cardiotoxic effect of doxorubicin in adult rats. Fiziol Zh. 2023; 69(6): 3-11. CrossRef
  6. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection. Cardiovascul Res. 2004; 61:372-85. CrossRef PubMed
  7. Angsutararux P, Luanpitpong S, Issaragrisil S. Chemotherapy-induced cardiotoxicity: Overview of the roles of oxidative stress. Oxid Med Cell Long. 2015; 2015:795602. CrossRef PubMed PubMedCentral
  8. Zhang YW, Shi J, Li YJ, Wei L. Cardiomyocyte death in doxorubicin-induced cardiotoxicity. Arch Immunol Ther Exp (Warsz). 2009; 57:435-45. CrossRef PubMed PubMedCentral
  9. Campos JC, Bozi LH, Bechara LR, Lima VM, Ferreira JC. Mitochondrial quality control in cardiac diseases. Front Physiol. 2016; 7:479. CrossRef PubMed PubMedCentral
  10. Nichols CG. KATP channels as molecular sensors of cellular metabolism. Nature 2006; 440(7083):470-6. CrossRef PubMed
  11. Strutynskyi RB. Protective properties of opening ATPsensitive potassium channels. Fiziol Zh. 2019;65(3):73-85. CrossRef
  12. Olson TM, Terzic A. Human KATP channelopathies: diseases of metabolic homeostasis. Pflüg Arch. 2010 Jul; 460(2):295-306. CrossRef PubMed PubMedCentral
  13. Sagach VF, Vavilova GL, Strutynska NA, Rudyk OV. The aging increase in the sensitivity of the mitochondrial permeability transition pore opening to conductors in the rat heart. Fiziol Zh. 2004; 50(2):49-63.
  14. Strutynska N, Strutynskyi R, Mys L, Luchkova A, Korkach Y, Goshovska Y, Sagach V. Exercise restores endogenous H2S synthesis and mitochondrial function in the heart of old rats. Eur J Clin Invest. 2022 Dec;52(12):e13829. CrossRef PubMed
  15. Kuthan H, Ullrich V, Estabrook RW. A quantitative test for superoxide radicals produced in biological systems. Biochem J. 1982; 203(3):551-8. CrossRef PubMed PubMedCentral
  16. Halliwell B, Grootveld M, Gutteridge JM. Methods for the measurement of hydroxyl radicals in biomedical systems: deoxyribose degradation and aromatic hydroxylation. Methods Biochem Anal. 1988; 33:59-90. CrossRef PubMed
  17. Huwiler M, Kohler H. Pseudo-catalytic degradation of hydrogen peroxide in the lactoperoxidase/H2O2 /iodide system. Eur J Biochem. 1984; 141(1): 69-74. CrossRef PubMed
  18. Strutyns'ka NA, Strutyns'kyĭ RB, Chorna SV, Semenykhina OM, Mys' LA, Moĭbenko OO, Sahach VF. New fluorine-containing openers of ATP-sensitive potassium channels flokalin and tioflokalin inhibit calcium-induced mitochondrial pore opening in rat hearts. Fiziol Zh. 2013;59(6):3-11. CrossRef
  19. Strutyns'kyi RB, Kotsuruba AV, Neshcheret AP, Shysh AN, Rovenets' RA, Moibenko AA. Cardioprotective effects of activation of ATP-sensitive potassium channels in experiments in vivo: influence on blood biochemical parameters following ischemia-reperfusion of the myocardium. Fiziol Zh. 2009;55(6):12-9.
  20. Strutyns'kyĭ RB, Kotsiuruba AV, Rovenets' RA, Strutyns'ka NA, Iagupols'kyĭ IuL, Sagach VF, Moĭbenko OO. Biochemical mechanisms of the cardioprotective effect of the K(ATP) channels opener flocalin (medicinal form) in ischemia-reperfusion of myocardium. Fiziol Zh. 2013; 59(4):16-27. CrossRef
  21. Wolf MB, Baynes, JW. The anticancer drug, doxorubicin, causes oxidant stress- induced endothelial dysfunction. Biochim Biophys Acta. 2006; 1760: 267-71. CrossRef PubMed
  22. Strutynsk'kyĭR B, Moĭbenko OO. Modelling of K+ ATP channel activity in normotensive and hypertensive animals. Fiziol Zh. 2000; 46(6):54-60.
  23. Strutyns'kyĭ RB. The vasodilation effects of flokalin, a fluorine-containing K(ATP) channel opener. Fiziol Zh. 2010; 56(4):59-65. CrossRef
  24. Strutyns'kyĭ RB, Rovenets' RA, Neshcheret OP, Tumanovs'ka LV, Boĭchuk TM, Dzhuran BV, Moĭbenko OO. Effect of medical form of flocalin on the course of myocardial reperfusion injury. Fiziol Zh. 2011; 57(1):55-65. CrossRef
  25. Strutyns'kyĭ RB, Rovenets' RA, Strutyns'ka NA, Neshcheret OP, Moĭbenko OO. The influence of activation of the ATP-sensitive potassium channels by flocalin on the function of the cardiovascular system. Fiziol Zh. 2013; 59(1):11-6. CrossRef
  26. Ahmadiasl N, Rostami A, Mohammadi NM, Rajabi F. Effects of norepinephrine and KCl on peripheral vessels in a doxorubicin induced model of heart failure. Pathophysiology. 2002; 8(4):259-62. CrossRef PubMed
  27. Olukman M, Can C, Erol A, Oktem G, Oral O, Cinar MG. Reversal of doxorubicin-induced vascular dysfunction by resveratrol in rat thoracic aorta: Is there a possible role of nitric oxide synthase inhibition? Anadolu Kardiyol Derg. 2009 Aug; 9(4):260-6.
  28. Clayton ZS, Brunt VE, Hutton DA, VanDongen NS, D'Alessandro A, Reisz JA, Ziemba BP, Seals DR. Doxorubicin-induced oxidative stress and endothelial dysfunction in conduit arteries is prevented by mitochondrial-specific antioxidant treatment. JACC CardioOncol. 2020 Sep; 2(3):475-88. CrossRef PubMed PubMedCentral
  29. Strutynskyi R, Strutynska N, Piven O, Mys L, Goshovska Y, Fedichkina R, Okhai I, Strutynskyi V, Dosenko V, Dobrzyn P, Sagach V. Upregulation of ATP-sensitive potassium channels as a potential mechanism of cardioprotection and vasorelaxation under the action of pyridoxal-5-phosphate in old rats. J Cardiovascul Pharmacol Ther. 2023 Jan-Dec; 28: 10742484231213175. CrossRef PubMed
  30. Zhao X, Alexander S, Zhang S, Zhu Y, Sieber T. Redox regulation of endothelial barrier integrity. Am J Physiol, Lung Cell Mol Physiol. 2001; 28:L879-86. CrossRef PubMed
  31. Sanada S, Kitakaze M, Asanuma H, Harada K, Ogita H, Node K, Takashima S, Sakata Y, Asakura M, Shinozaki Y, Mori H, Kuzuya T, Hori M. Role of mitochondrial and sarcolemmal KATP channels in ischaemic preconditioning of the canine heart. Am J Physiol Heart Circ Physiol. 2001 Jan; 280(1):H256-63. CrossRef PubMed
  32. Pyvovar SM, Strutyns'kyĭ RB, Iagupol's'kyĭ LM, Moĭbenko OO. Study of the mechanism of action of novel fluoro-containing analogues of diazoxide on the vascular tone. Fiziol Zh. 2004; 50(2):27-33.

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.